Edgestream Partners, L.P. Seagen Inc. Transaction History

Edgestream Partners, L.P.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 10, 2023	BUY	$187.64 - $206.25 $2.87 Million - $3.16 Million	15,305 Added 1202.28%	16,578 $3.19 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $162,422 - $258,520	1,273 New	1,273 $257,000
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $1.53 Million - $2.04 Million	11,338 Added 24.8%	57,053 $7.81 Million
Q2 2022 Aug 12, 2022	BUY	$108.81 - $179.33 $341,119 - $562,199	3,135 Added 7.36%	45,715 $8.09 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $1.11 Million - $1.46 Million	-9,249 Reduced 17.85%	42,580 $6.13 Million

Q4 2021 Feb 15, 2022	BUY	$142.57 - $190.86 $4.52 Million - $6.05 Million	31,683 Added 157.27%	51,829 $8.01 Million
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $57,977 - $69,116	407 Added 2.06%	20,146 $3.42 Million
Q2 2021 Aug 10, 2021	BUY	$135.08 - $161.1 $2.67 Million - $3.18 Million	19,739 New	19,739 $3.12 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Edgestream Partners, L.P., based on Form 13F filings with the SEC.

Stay updated on Edgestream Partners, L.P. with notifications on news.